The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy

Context: Diagnosis of primary aldosteronism (PA) for many patients depends on positive results for the saline infusion test (SIT). Plasma aldosterone is often measured by immunoassays, which can return inaccurate results. Objective: This study aimed to establish whether differences in aldosterone me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical endocrinology and metabolism 2022-05, Vol.107 (5), p.e2027
Hauptverfasser: Eisenhofer, Graeme, Kurlbaum, Max, Peitzsch, Mirko, Constantinescu, Georgiana, Remde, Hanna, Schulze, Manuel, Kaden, Denise, Muller, Lisa Marie, Fuss, Carmina T, Kunz, Sonja, Kotodziejczyk-Kruk, Sylwia, Gruber, Sven, Prejbisz, Aleksander, Beuschlein, Felix, Williams, Tracy Ann, Reincke, Ma, Lenders, Jacques W.M, Bidlingmaier, Ma
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Context: Diagnosis of primary aldosteronism (PA) for many patients depends on positive results for the saline infusion test (SIT). Plasma aldosterone is often measured by immunoassays, which can return inaccurate results. Objective: This study aimed to establish whether differences in aldosterone measurements by immunoassay versus mass spectrometry (MS) might impact confirmatory testing for PA. Methods: This study, involving 240 patients tested using the SIT at 5 tertiary care centers, assessed discordance between immunoassay and MS-based measurements of plasma aldosterone. Results: Plasma aldosterone measured by Liaison and iSYS immunoassays were respectively 86% and 58% higher than determined by MS. With an immunoassay-based SIT cutoff for aldosterone of 170 pmol/L, 78 and 162 patients had, respectivel, negative and positive results. All former patients had MS-based measurements of aldosterone < 117 pmol/L, below MS-based cutoffs of 162 pmol/L. Among the 162 patients with pathogenic SIT results, MS returned nonpathologic results in 62, including 32 under 117 pmol/L. Repeat measurements by an independent MS method confirmed nonpathogenic results in 53 patients with discordant results. Patients with discordant results showed a higher [P< 0.0001) prevalence of nonlateralized than lateralized adrenal aldosterone production than patients with concordant results (83% vs 28%) Among patients with nonlateralized aldosterone production, 66% had discordant results. Discordance was more prevalent for the Liaison than iSYS immunoassay (32% vs 16%; P = 0.0065) and was eliminated by plasma purification to remove interferents. Conclusion: These findings raise concerns about the validity of immunoassay-based diagnosis of PA in over 60% of patients with presumed bilateral disease. We provide a simple solution to minimize immunoassay inaccuracy-associated misdiagnosis of PA. Key Words: aldosterone, renin, adrenal cortex, mass spectrometry, diagnosis, interference Abbreviations: APM, aldosterone-producing micronodule; ARR, aldosterone to renin ratio; AVS, adrenal vein sampling; LC-MS/MS, liquid chromatography-tandem mass spectrometry; PA, primary aldosteronism; PR0SALD0, PROspective study on the diagnostic value of Steroid profiling in primary ALDOsteronism; ROC, receiver-operating characteristic; SIT, saline infusion test.
ISSN:0021-972X
DOI:10.1210/clinem/dqab924